These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20590862)

  • 21. Increased thrombin generation and fibrinogen level after therapeutic plasma transfusion: relation to bleeding.
    Schols SE; van der Meijden PE; van Oerle R; Curvers J; Heemskerk JW; van Pampus EC
    Thromb Haemost; 2008 Jan; 99(1):64-70. PubMed ID: 18217136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Exploration of hemostasis in current practice].
    Aiach M; Gaussem P
    Ann Pharm Fr; 1996; 54(1):21-4. PubMed ID: 8702189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of reagent and instrument on prothrombin times, activated partial thromboplastin times and patient/control ratios.
    Naghibi F; Han Y; Dodds WJ; Lawrence CE
    Thromb Haemost; 1988 Jun; 59(3):455-63. PubMed ID: 3187932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombin generation testing for monitoring hemophilia treatment: a clinical perspective.
    Salvagno GL; Berntorp E
    Semin Thromb Hemost; 2010 Oct; 36(7):780-90. PubMed ID: 20978999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Global hemostasis in pregnancy: are we using thromboelastography to its full potential?
    Othman M; Falcón BJ; Kadir R
    Semin Thromb Hemost; 2010 Oct; 36(7):738-46. PubMed ID: 20978994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tailoring haemostatic treatment to patient requirements - an update on monitoring haemostatic response using thrombelastography.
    Sørensen B; Ingerslev J
    Haemophilia; 2005 Nov; 11 Suppl 1():1-6. PubMed ID: 16219042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of telavancin on coagulation test results.
    Barriere SL; Goldberg MR; Janc JW; Higgins DL; Macy PA; Adcock DM
    Int J Clin Pract; 2011 Jul; 65(7):784-9. PubMed ID: 21564449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombelastography is better than PT, aPTT, and activated clotting time in detecting clinically relevant clotting abnormalities after hypothermia, hemorrhagic shock and resuscitation in pigs.
    Martini WZ; Cortez DS; Dubick MA; Park MS; Holcomb JB
    J Trauma; 2008 Sep; 65(3):535-43. PubMed ID: 18784565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Study on the hemostatic effects in raw and charred Mongolian drug Agi and its mechanism].
    Zhong BX; Zhang W; Liu WZ; Pang ZR; Cui J
    Zhong Yao Cai; 2011 Jun; 34(6):872-6. PubMed ID: 22017002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prothrombin time and partial thromboplastin time assay considerations.
    Ng VL
    Clin Lab Med; 2009 Jun; 29(2):253-63. PubMed ID: 19665677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticoagulant activity of captopril.
    Brecher AS; Murrey SJ; Gray KD; Poulimenos JN
    J Cardiovasc Pharmacol; 2008 Jan; 51(1):99-105. PubMed ID: 18209575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Modification of the global coagulation tests for the dog. Significance for the monitoring of heparin therapy].
    Mischke R; Nolte I
    Tierarztl Prax; 1991 Oct; 19(5):561-6. PubMed ID: 1759273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Standardization of coagulation tests.
    Opartkiattikul N
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro hemostatic properties of French lyophilized plasma.
    Martinaud C; Civadier C; Ausset S; Verret C; Deshayes AV; Sailliol A
    Anesthesiology; 2012 Aug; 117(2):339-46. PubMed ID: 22739764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diagnosis of hemostasis disorders].
    Kraft W
    Tierarztl Prax; 1992 Aug; 20(4):355-7. PubMed ID: 1412425
    [No Abstract]   [Full Text] [Related]  

  • 36. The value of rotation thromboelastometry to monitor disturbed perioperative haemostasis and bleeding risk in patients with cardiopulmonary bypass.
    Reinhöfer M; Brauer M; Franke U; Barz D; Marx G; Lösche W
    Blood Coagul Fibrinolysis; 2008 Apr; 19(3):212-9. PubMed ID: 18388501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of platelets and platelet-derived material on the activated partial thromboplastin time (Cephotest) coagulation test.
    Mendelsohn EE; Solum NO; Brosstad F
    Scand J Clin Lab Invest; 2005; 65(4):321-32. PubMed ID: 16076687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests.
    Tripodi A; Salerno F; Chantarangkul V; Clerici M; Cazzaniga M; Primignani M; Mannuccio Mannucci P
    Hepatology; 2005 Mar; 41(3):553-8. PubMed ID: 15726661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombin generation in paediatric patients with congenital heart disease. Determination by calibrated automated thrombography.
    Koestenberger M; Cvirn G; Rosenkranz A; Leschnik B; Raith W; Muntean W
    Hamostaseologie; 2008 Oct; 28 Suppl 1():S61-6. PubMed ID: 18958342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of TAK-442, a novel orally active direct factor Xa inhibitor, and ximelagatran, a thrombin inhibitor, on factor V-mediated feedback on coagulation cascade and bleeding.
    Konishi N; Hiroe K; Kawamura M
    Thromb Haemost; 2010 Sep; 104(3):504-13. PubMed ID: 20664909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.